HARBOURVEST PARTNERS LLC Quant / Systematic

Location: Boston, MA

CIK: 0001201001 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 12, 2020

Total Value: $270M (100.0% shares, 0.0% debt)

Holdings (35)

Solarwinds Corp. 59.3%
Value $160M Shares 7,872,801 Est. Cost $13.83 Unrealized
KLDO Cornerstone OnDemand Inc. 8.7%
Value $23.43M Shares 1,920,027 Est. Cost $11.01 Unrealized -37.1%
Evelo Biosciences, Inc. 6.0%
Value $16.14M Shares 3,063,505 Est. Cost $8.87 Unrealized
Axcella Health, Inc. 4.8%
Value $12.97M Shares 2,807,981 Est. Cost $7.18 Unrealized
TDOC TelaDoc Health, Inc. 4.1%
Value $11.17M Shares 50,943 Est. Cost $211.77 Unrealized 0.0%
1Life Healthcare, Inc. 3.7%
Value $9.968M Shares 351,480 Est. Cost $28.36 Unrealized
Rubius Therapeutics, Inc. 1.8%
Value $4.944M Shares 986,878 Est. Cost $24.00 Unrealized
PluralSight, Inc. 1.1%
Value $3.029M Shares 176,807 Est. Cost $21.09 Unrealized
PGNY Progyny, Inc. 1.0%
Value $2.577M Shares 87,574 Est. Cost $27.57 Unrealized 0.0%
IVERIC Bio, Inc. 0.9%
Value $2.497M Shares 442,810 Est. Cost $5.26 Unrealized
Spark Networks SE 0.9%
Value $2.458M Shares 502,576 Est. Cost $5.53 Unrealized
LC LendingClub Corp. 0.9%
Value $2.418M Shares 513,440 Est. Cost $12.90 Unrealized -59.2%
NTNX Nutanix, Inc. 0.9%
Value $2.352M Shares 106,049 Est. Cost $22.86 Unrealized 0.0%
PD PagerDuty, Inc. 0.7%
Value $1.841M Shares 67,891 Est. Cost $28.11 Unrealized 0.0%
SFIX Stitchfix, Inc. 0.7%
Value $1.806M Shares 66,571 Est. Cost $30.60 Unrealized -16.1%
Crispr Therapeutics AG 0.7%
Value $1.793M Shares 21,439 Est. Cost $83.63 Unrealized
YEXT Yext, Inc. 0.6%
Value $1.748M Shares 115,147 Est. Cost $22.86 Unrealized -26.2%
Zuora, Inc. 0.6%
Value $1.695M Shares 163,894 Est. Cost $18.77 Unrealized
Constellation Pharmaceuticals, Inc. 0.4%
Value $1.005M Shares 49,614 Est. Cost $20.26 Unrealized
PHR Phreesia, Inc. 0.3%
Value $789K Shares 24,562 Est. Cost $29.77 Unrealized 0.0%
VCYT Veracyte, Inc. 0.3%
Value $766K Shares 23,591 Est. Cost $31.78 Unrealized 0.0%
LYFT Lyft, Inc. 0.3%
Value $710K Shares 25,785 Est. Cost $39.72 Unrealized -25.2%
Trevena, Inc. 0.3%
Value $699K Shares 233,850 Est. Cost $6.45 Unrealized
CTMX Cytomx Therapeutics, Inc. 0.2%
Value $527K Shares 79,193 Est. Cost $25.54 Unrealized -71.0%
Proteostasis Therapeutics, Inc. 0.2%
Value $485K Shares 440,627 Est. Cost $7.82 Unrealized
Castlight Health, Inc. 0.1%
Value $394K Shares 349,070 Est. Cost $2.63 Unrealized
ARVN Arvinas, Inc. 0.1%
Value $393K Shares 16,666 Est. Cost $28.98 Unrealized 0.0%
AR Antero Resources LLC 0.1%
Value $363K Shares 131,895 Est. Cost $7.21 Unrealized -56.1%
Epizyme, Inc. 0.1%
Value $295K Shares 24,686 Est. Cost $16.04 Unrealized
BDTX Black Diamond Therapeutics, Inc. 0.1%
Value $290K Shares 9,581 Est. Cost $30.44 Unrealized 0.0%
XGN Exagen, Inc. 0.1%
Value $282K Shares 25,982 Est. Cost $19.85 Unrealized -35.1%
REAL The RealReal, Inc. 0.0%
Value $106K Shares 7,300 Est. Cost $15.29 Unrealized 0.0%
NextCure, Inc. 0.0%
Value $88,000 Shares 10,044 Est. Cost $37.04 Unrealized
Ramaco Resources, Inc. 0.0%
Value $52,000 Shares 14,951 Est. Cost $5.80 Unrealized
HNRG Hallador Energy Resources, Inc. 0.0%
Value $9,000 Shares 14,270 Est. Cost $5.36 Unrealized -86.5%